Table 2 Univariate and multivariate analysis for neurological outcome three months after cardiac arrest
Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
OR | 95%CI | P | OR | 95%CI | P | |
Gender | 0.886 | 0.556–1.412 | 0.611 | / | / | / |
Age ≥ 65 year | 2.029 | 1.326–3.106 | 0.001 | 2.614 | 1.501–4.552 | 0.001 |
Hypertension | 0.909 | 0.598–1.382 | 0.656 | / | / | / |
Diabetes | 1.454 | 0.885–2.390 | 0.140 | / | / | / |
COPD/Asthma | 1.641 | 0.916–2.942 | 0.096 | / | / | / |
Chronic Heart Failure | 1.218 | 0.726–2.043 | 0.456 | / | / | / |
Chronic Renal Failure | 1.340 | 0.756–2.376 | 0.316 | / | / | / |
Liver cirrhosis | 3.192 | 0.901–11.306 | 0.072 | / | / | / |
Previous Neurol Disease | 2.301 | 1.187–4.462 | 0.014 | 3.002 | 1.348–6.687 | 0.007 |
Corticoids | 1.778 | 1.056–2.996 | 0.031 | / | / | / |
Chronic Anticoagulation | 0.979 | 0.567–1.690 | 0.938 | / | / | / |
Witnessed arrest | 0.387 | 0.196–0.762 | 0.006 | 0.391 | 0.172–0.887 | 0.025 |
Bystander CPR | 0.486 | 0.3040.0775 | 0.002 | 0.502 | 0.279–0.903 | 0.021 |
Time to ROSC ≥ 17 min | 2.257 | 1.461–3.487 | < 0.001 | / | / | / |
Non-cardiac cause | 1.722 | 1.119–2.650 | 0.013 | / | / | / |
None-shockable rhythm | 3.458 | 2.238–5.342 | < 0.001 | 2.706 | 1.549–4.729 | < 0.001 |
Shock | 1.983 | 1.303–3.020 | 0.001 | / | / | / |
Vasopressor therapy | 2.043 | 1.266–3.296 | 0.003 | / | / | / |
AKI | 2.243 | 1.466–3.432 | < 0.001 | 2.043 | 1.171–3.565 | 0.012 |
Lac ≥ 6 mmol/L | 1.893 | 1.211–2.958 | 0.005 | / | / | / |
Epinephrine dose ≥ 2.5 mg | 2.516 | 1.641–3.859 | < 0.001 | 2.018 | 1.072–3.800 | 0.030 |